Refractory obsessive-compulsive disorder: State-of-the-art treatment

Journal of Clinical Psychiatry

Volumn 63, Issue SUPPL. 6, 2002, Pages 20-29

  Hollander, Eric ^a   Bienstock, Carol A ^a   Koran, Lorrin M ^a   Pallanti, Stefano ^a   Marazziti, Donatella ^a   Rasmussen, Steven A ^a   Ravizza, Luigi ^a   Benkelfat, Chawkie ^a   Saxena, Sanjaya ^a   Greenberg, Benjamin D ^a   Sasson, Yehuda ^a   Zohar, Joseph ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSPIRONE; CITALOPRAM; CLOMIPRAMINE; CLONAZEPAM; CLONIDINE; CLORGYLINE; CLOZAPINE; CYPROTERONE ACETATE; FENFLURAMINE; FLUOXETINE; FLUVOXAMINE; GABAPENTIN; INOSITOL; LIOTHYRONINE; LITHIUM; MONOAMINE OXIDASE INHIBITOR; MORPHINE; NORCLOMIPRAMINE; OLANZAPINE; PHENELZINE; PINDOLOL; RISPERIDONE; SEROTONIN 1D AGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SUMATRIPTAN; TRAZODONE; TRYPTOPHAN; UNINDEXED DRUG; VENLAFAXINE;

BEHAVIOR THERAPY; BRAIN SURGERY; CAPSULA INTERNA; CLINICAL TRIAL; COGNITIVE THERAPY; COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; CONTROLLED RELEASE FORMULATION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; ELECTROCONVULSIVE THERAPY; EOSINOPHILIA MYALGIA SYNDROME; HUMAN; OBSESSION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SCHIZOPHRENIA; SIDE EFFECT; TRANSCRANIAL MAGNETIC STIMULATION;

ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; FLUVOXAMINE; HUMANS; MORPHINE; MULTICENTER STUDIES; NEUROTRANSMITTER UPTAKE INHIBITORS; OBSESSIVE-COMPULSIVE DISORDER; PIRENZEPINE; PRACTICE GUIDELINES; RETROSPECTIVE STUDIES; REVIEW LITERATURE; SEROTONIN UPTAKE INHIBITORS; SUMATRIPTAN; TREATMENT OUTCOME;

EID: 0036231557     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (73)

1. A double-blind placebo-controlled study of the efficacy and safety of controlled release fluvoxamine in patients with obsessive-compulsive disorder
2. The International Treatment Refractory OCD Consortium: Preliminary findings
3. 11C-αMT)
4. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder
5. Pindolol augmentation in treatment-resistant obsessive compulsive disorder: A double-blind placebo controlled trial
6. Therapeutic effect and safety of adjunctive risperidone in refractory obsessive-compulsive disorder
7. Risperidone augmentation of SR treatment for refractory obsessive-compulsive disorder
8. Risperidone augmentation in refractory obsessive-compulsive disorder: An open-label study
9. Lithium and tryptophan augmentation in clomipramine-resistant obsessive-compulsive disorder
10. Combined lithium-tricyclic treatment of obsessive-compulsive disorder
11. Lithium augmentation of clomipramine
12. A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: Lack of efficacy
13. Sequential administration of augmentation strategies in treatment-resistant obsessive-compulsive disorder: Preliminary findings
14. Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder
15. Buspirone in obsessional compulsive disorder: A prospective case study
16. Fenfluramine augmentation of serotonin reuptake blockade antiobsessional treatment
17. Obsessive-compulsive disorder successfully treated with trazodone
18. Efficacy of trazodone as an anti-obsessional agent
19. A double-blind, placebo-controlled study of trazodone in patients with obsessive-compulsive disorder
20. The use of thyroid supplements to augment antidepressant medication
21. Triiodothyronine potentiation of fluoxetine in depressed patients
22. Triiodothyronine augmentation in the treatment of refractory depression: A meta-analysis
23. Thyroid hormone supplementation of fluoxetine in the treatment of major depression
24. A controlled comparison of adjuvant lithium carbonate or thyroid hormone in clomipramine-treated patients with obsessive-compulsive disorder
25. Clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders
26. Obsessive-compulsive symptoms during treatment with clozapine in a patient with schizophrenia
27. Development of obsessive-compulsive symptoms during clozapine treatment in schizophrenia and its positive response to clomipramine
28. Lack of efficacy of clozapine monotherapy in refractory obsessive-compulsive disorder
29. Rapid benefit of intravenous pulse loading of clomipramine in obsessive-compulsive disorder
30. Intravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: A placebo-controlled study
31. Open trial of intravenous clomipramine in five treatment-refractory patients with obsessive-compulsive disorder
32. Placebo-controlled trial of fluoxetine and phenelzine for obsessive-compulsive disorder
33. Obsessive-compulsive disorder: A double-blind trial of clomipramine and clorgyline
34. Clomipramine versus phenelzine in obsessive-compulsive disorder: A controlled clinical trial
35. Clomipramine, clonazepam, and clonidine treatment of obsessive-compulsive disorder
36. Clonazepam as an augmenting agent in the treatment of childhood-onset obsessive-compulsive disorder
37. Clonazepam treatment of obsessions and compulsions
38. Inositol treatment of obsessive-compulsive disorder
39. Inositol augmentation of serotonin reuptake inhibitors in treatment-refractory obsessive-compulsive disorder: An open trial
40. Current and experimental therapeutics of obsessive-compulsive disorder
41. Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: Behavioral findings
42. Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: A preliminary study
43. Antiandrogenic treatment of obsessive-compulsive neurosis
44. Gamma capsulotomy in intractable OCD
45. Fluvoxamine/pimozide treatment of concurrent Tourette's and obsessive-compulsive disorder
46. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder: A double-blind, placebo-controlled study in patients with and without tics
47. Treatment of obsessive-compulsive syndromes in schizophrenia
48. Augmentation of SSRI response in refractory OCD using adjunctive olanzapine: A placebo controlled trial
49. Olanzapine treatment for schizophrenia patients with refractory OCD: An open-label case series
50. Emergence of obsessive compulsive symptoms during treatment with clozapine
51. More on obsessive-compulsive symptoms and clozapine
52. A case report of risperidone-induced obsessive-compulsive symptoms
53. Worsening of obsessive-compulsive symptoms following treatment with olanzapine
54. Olanzapine induced obsessive compulsive disorder
55. Development of obsessive-compulsive symptoms during clozapine treatment
56. Sertraline in the treatment of clozapine induced obsessive-compulsive behavior
57. Clozapine and paroxetine in the treatment of schizophrenia with obsessive-compulsive features
58. Obsessive-compulsive symptoms in schizophrenia: A comparison of olanzapine and placebo
59. Controlled study of gabapentin augmentation of fluoxetine in OCD: Effects on symptoms and on cortical excitability
60. Gabapentin augmentation for fluoxetine-treated patients with obsessive-compulsive disorder
61. Altered cortical excitability on obsessive-compulsive disorder
62. Modification of cortical excitability induced by gabapentin: A study by transcranial magnetic stimulation
63. Treatment of obsessive-compulsive disorder with venlafaxine
64. Open treatment of obsessive-compulsive disorder with venlafaxine: A series of 10 cases
65. Venlafaxine for treatment of obsessive-compulsive disorder
66. Venlafaxine in OCD
67. Oral morphine in treatment resistant OCD
68. A possible new treatment approach to obsessive-compulsive disorder
69. Rapid remission of OCD with tramadol hydrochloride
70. Open-label pilot study of tramadol hydrochloride in treatment-refractory obsessive-compulsive disorder
71. 1D receptors and obsessive-compulsive disorder
72. Anterior gamma capsulotomy for intractable OCD